2021-01-11,RedHill Biopharma Announces $10 Million Bought Deal Offering
2021-01-11,RedHill's Partner Cosmo Pharmaceuticals Successfully Completes Phase 2 Study of Rifamycin SV-MMX 600mg in IBS-D
2021-01-11,RedHill's Partner Cosmo Pharmaceuticals Successfully Completes Phase 2 Study of Rifamycin SV-MMX 600mg in IBS-D
2021-01-08,"Government of Canada awards contract for inspection, repair and overhaul of service boats"
2021-01-07,RedHill's (RDHL) RHB-204 Gets FDA Fast Track Designation
2021-01-06,RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease
2021-01-04,RedHill (RDHL) COVID-19 Drug Shows Promise in Mid-Stage Study
2020-12-31,RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib
2020-12-31,RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib
2020-12-28,Is the Options Market Predicting a Spike in RedHill Biopharma (RDHL) Stock?
2020-12-22,RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue
2020-12-15,RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Model
2020-12-15,RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Model
2020-12-14,RedHill Biopharma Added to NASDAQ Biotechnology Index
2020-12-07,RedHill Biopharma Extends Talicia® Unrestricted National and Regional Commercial Coverage to Over 40 Million Additional Americans
2020-11-29,RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19
2020-11-27,Do Hedge Funds Love RedHill Biopharma Ltd (RDHL)?
2020-11-27,RedHill (RDHL) Expands Opaganib Manufacturing Capacity in US
2020-11-25,RedHill Biopharma Expands Their U.S.-Based Manufacturing Capacity of Opaganib for COVID-19
2020-11-25,RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19
2020-11-24,RedHill Biopharma to Present at Evercore ISI HealthCONx and Piper Sandler Healthcare Conferences
2020-11-23,RedHill Biopharma to Present at Evercore ISI HealthCONx and Piper Sandler Healthcare Conferences
2020-11-23,RedHill Biopharma to Present at Evercore ISI HealthCONx and Piper Sandler Healthcare Conferences
2020-11-20,RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease
2020-11-19,"RedHill Biopharma's Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease"
2020-11-19,RedHill Announces Unanimous DSMB Recommendation to Continue Phase 2/3 COVID-19 Study with Opaganib
2020-11-19,RedHill Announces Unanimous DSMB Recommendation to Continue Phase 2/3 COVID-19 Study with Opaganib
2020-11-18,RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks
2020-11-18,RedHill (RDHL) to Begin Study on Second Coronavirus Candidate
2020-11-17,RedHill (RDHL) Closes Enrollment for Phase II Coronavirus Study
2020-11-17,"RedHill Biopharma's Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease"
2020-11-17,"RedHill Biopharma's Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease"
2020-11-16,RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks
2020-11-16,RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks
2020-11-13,RedHill Biopharma to Present at German Equity Forum 2020
2020-11-12,RedHill Biopharma (RDHL) Q3 2020 Earnings Call Transcript
2020-11-12,Recap: Redhill Biopharma Q3 Earnings
2020-11-12,"RedHill Biopharma Provides Q3/2020 Results and Highlights, Including 300% Talicia Prescription Growth"
2020-11-12,RedHill Biopharma Ltd. to Host Earnings Call
2020-11-11,A Preview Of Redhill Biopharma's Earnings
2020-11-05,"RedHill Biopharma to Host Third Quarter Financial Results and Business Highlights Webcast on November 12, 2020"
2020-11-04,RedHill Biopharma Receives U.S. Patent Allowance Covering Opaganib and RHB-107 Combination
2020-10-26,RedHill Biopharma Presents New Data from Talicia®s Phase 3 Studies at ACG 2020 Focused on Achieving Successful First-Line Treatment in H. pylori Eradication
2020-10-15,RedHill's (RDHL) RHB-204 Gets FDA Orphan Drug Designation
2020-10-14,RedHill Biopharma Announces FDA Orphan Drug Designation for RHB-204 for the Treatment of NTM Infections
2020-10-13,REFILE-Israel's Redhill Biopharma signs manufacturing deal for potential COVID-19 treatment
2020-10-13,RedHill Biopharma Announces Partnerships to Expand Manufacturing for COVID-19 Therapeutic Candidate Opaganib
2020-10-08,RedHill Biopharma Adds Israel Rights to Movantik® From AstraZeneca
2020-10-07,RedHill Biopharmas Opaganib COVID-19 Study Passes Second Independent Committee Review
2020-10-06,RedHill Biopharma to Present at BIO Investor and BIO-Europe 2020 Virtual Conferences
2020-09-23,"Veeva Systems Again Enlisted To Help A Covid-19 Treatment Study, Making It Stock Of The Day"
2020-09-23,RedHill Gets Nod in Brazil for Coronavirus Study on Opaganib
2020-09-23,Veeva Systems Enlisted To Help In Study Of Possible Covid-19 Treatment
2020-09-23,Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19
2020-09-23,RedHill Gets Brazils Nod For Covid-19 Study With Opaganib
2020-09-22,Brazil Approves RedHill Biopharmas Phase 2/3 COVID-19 Study with Opaganib
2020-09-09,RedHill to Present at the Morgan Stanley Annual Global Healthcare Conference and Additional September Events
2020-09-08,RedHill Biopharmas Opaganib Demonstrates Complete Inhibition of SARS-CoV-2
2020-09-03,RedHill Biopharma's Opaganib Awarded COVID-19 Grant by State of Pennsylvania
2020-08-31,LD Micro - 360 Companies Set to Present - this Week
2020-08-27,"RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy"
2020-08-13,RedHill Biopharma (RDHL) Q2 2020 Earnings Call Transcript
2020-08-13,Recap: Redhill Biopharma Q2 Earnings
2020-08-13,RedHill Biopharma Provides Q2/2020 Financial Results and Operational Highlights
2020-08-13,RedHill Biopharma and Cosmo Pharmaceuticals to Expand Strategic Partnership with Exclusive Licensing Agreement and Manufacturing Agreement for Multiple Products
2020-08-11,RedHill Biopharmas Phase 2/3 COVID-19 Study Approved in Mexico
2020-08-07,"RedHill Biopharma to Host Second Quarter Financial Results and Business Highlights Conference Call and Webcast on August 13, 2020"
2020-08-06,RedHill Biopharmas Phase 2/3 COVID-19 Study Approved in Mexico
2020-08-05,RedHill Biopharma to Participate in Upcoming BTIG and Intellisight Conferences
2020-08-03,"49 Public Companies to Present at the SNN Network Virtual Conference : August 3-6, 2020"
2020-08-03,RedHill Biopharma Announces New Agreement with Daiichi Sankyo for Movantik®
2020-07-31,RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 Study with RHB-204 for NTM Infections
2020-07-30,RedHill Biopharma Initiates Global Phase 2/3 Study for COVID-19
2020-07-28,RedHill Biopharma Publishes Positive IBS-D Phase 2 Study Data in The American Journal of Gastroenterology
2020-07-27,RedHill Biopharma Increases Patient Access to Talicia® with EnvisionRx Formularies
2020-07-22,RedHill Biopharma Accelerates Phase 2/3 COVID-19 Program with Addition of Brazil and Mexico
2020-07-21,RedHill Biopharma Seeks SEC Review of Suspicious Trading Activity
2020-07-16,RedHill Biopharma Receives Approval for Phase 2/3  COVID-19 Study in Russia
2020-07-01,RedHill Biopharma to Present at the Sachs Novel Coronavirus Investment Forum
2020-06-30,RedHill (RDHL) to Study Opaganib for Severe Coronavirus in UK
2020-06-29,RedHill Biopharma Receives Approval for COVID-19 Phase 2/3 Study with Opaganib in the UK
2020-06-29,Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
2020-06-24,Publication of Data from Severe COVID-19 Patients Shows Substantial Benefit to Patients Treated with RedHills Opaganib Compared to Matched Case-Control Group
2020-06-23,"Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020"
2020-06-22,RedHill Biopharma to Present at Virtual Life Sciences Investor Forum on June 25
2020-06-18,RedHill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK
2020-06-18,RedHill Biopharma to Present at Virtual Life Sciences Investor Forum on June 25
2020-06-11,RedHill Files CTA for Coronavirus Study on Opaganib in Russia
2020-06-10,RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib
2020-06-08,RedHill Biopharma to Provide Update on its COVID-19 and other Development Programs at MedInvest Virtual Infectious Diseases and Immunology Conference
2020-06-01,RedHill Biopharma to Present at BIO Digital
2020-05-28,RedHill Biopharma to Present at Jefferies Virtual Healthcare Conference
2020-05-27,RedHill Biopharma (RDHL) Q1 2020 Earnings Call Transcript
2020-05-27,Recap: Redhill Biopharma Q1 Earnings
2020-05-27,RedHill Biopharma Provides Q1/2020 Financial Results and Recent Highlights Including Initial Movantik® Revenues
2020-05-27,RedHill Biopharma Ltd. to Host Earnings Call
2020-05-20,"RedHill Biopharma to Host First Quarter Financial Results Conference Call on May 27, 2020"
2020-05-15,Is Redhill Biopharma (RDHL) Stock Outpacing Its Medical Peers This Year?
2020-05-11,RedHill Biopharma to Present at the UBS Virtual Global Healthcare Conference
2020-05-08,RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S.
